Christopher A. Viehbacher Salary and Compensation - BIOGEN INC. CEO Pay 2024

In fiscal year 2024, Christopher A. Viehbacher, President and CEO of BIOGEN INC. (BIIB), received total compensation of $175702.7 million.

Christopher A. Viehbacher's compensation breakdown includes: base salary of $1.6 million, stock awards valued at $18.0 million, option awards of $175678.6 million, non-equity incentive compensation of $4.3 million, and other compensation of $244K.

Compared to fiscal year 2023, Christopher A. Viehbacher's total compensation increased 1595759% from $11.0 million to $175702.7 million.

BIOGEN INC. (BIIB) Executive Pay 2024

BIOGEN INC.'s top 9 named executive officers received combined total compensation of $213313.5 million in fiscal year 2024.

The named executive officers disclosed in BIOGEN INC.'s 2024 proxy statement are:Christopher A. Viehbacher (President and CEO) with total compensation of $175702.7 million, Michael R. McDonnell (Executive Vice President, Chief Financial Officer) with total compensation of $10644.1 million, Susan H. Alexander (Executive Vice President, Chief Legal Officer) with total compensation of $8154.2 million, Priya A. Singhal (Head of Development) with total compensation of $10643.7 million, Nicole C. Murphy (Head of Pharmaceutical Operations and Technology) with total compensation of $8153.4 million, A. McDonnell (CFO) with total compensation of $5.5 million, S. Murphy (Executive Vice President, General Counsel and Corporate Secretary) with total compensation of $4.3 million, R. Alexander (Executive Vice President, Chief Administrative Officer and Chief Human Resources Officer) with total compensation of $3.0 million, and I. Izzar (Executive Vice President, Chief Information Officer) with total compensation of $2.6 million.